This study enrolls adults who are hospitalized for acute ischemic stroke. The purpose of this study is to learn how safe and effective the pRESET Thrombectomy Device is for the treatment of this condition and for removing the blood clot.
You will be in this study for about 3 months after you have your procedure. During the procedure, either the pRESET or the market approved Solitaire device will be used to treat your blood clot. You will be randomized (like the flip of a coin) to have one of the two devices. After your procedure, you will have 2 study visits in-person and others by phone. Study takes place at BUffalo General Hospital and gates Vascular Institute (875 Ellicott St. Buffalo, NY 14203).
To determine the safety and effectiveness of pRESET for the treatment of acute ischemic stroke within 8
hours of symptom onset (defined as time patient was last seen well) due to large vessel occlusion and to
compare safety and effectiveness to the predicate device, Solitaire??? Platinum revascularization device
Adults ages 18+.
Currently admitted to the hospital for an acute ischemic stroke that began in the last 8 hours.
Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the
contact information above or email email@example.com and someone will assist you.
Your information will be shared only with the research study team for recruitment purposes and designated CTSI personnel for project quality
assurance and will remain confidential. Your information will be stored indefinitely. Should you no longer want this information to be provided
in the aforementioned ways, please contact firstname.lastname@example.org.